ArticleReproductive sciences (Thousand Oaks, Calif.)2025

HERC2 as a Potential Biomarker for Prognosis and Response to Bevacizumab in Ovarian Cancer: A Bioinformatics Approach.

Fatih Yay et al.PubMed ↗Publisher ↗

No numbers read from the abstract.